Transaction in Own Shares

Summary by AI ^BETAClose X

Smith & Nephew plc has purchased 1,204,120 ordinary shares between June 5 and June 11, 2026, as part of its $250 million share buyback program. The average price paid per share during this period was £11.5122, with the lowest at £11.2750 and the highest at £11.8050. Since May 8, 2026, the company has repurchased a total of 6,464,816 shares for $97,543,114.44. Following these transactions, Smith & Nephew holds 30,087,389 shares in treasury, leaving 847,646,361 ordinary shares outstanding.

Disclaimer*

Smith & Nephew Plc

12 June 2026

Smith & Nephew plc
Transactions in own shares

Smith & Nephew plc (the "Company") announces that from 5 June 2026 up to and including 11 June 2026 it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $250 million share buyback programme announced on 6 May 2026 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 6 May 2026.

Date of purchase	Aggregate number of ordinary shares purchased	Lowest price paid per ordinary share	Highest price paid per ordinary share	Average price paid per ordinary share
5 Jun 2026	238,997	1,143.50p	1,155.00p	1,150.80p
8 Jun 2026	238,208	1,127.50p	1,145.00p	1,140.36p
9 Jun 2026	243,567	1,136.00p	1,162.50p	1,154.37p
10 Jun 2026	234,711	1,153.00p	1,180.50p	1,161.90p
11 Jun 2026	248,637	1,138.50p	1,157.00p	1,148.88p

The Company intends to hold these shares in Treasury and then either cancel them or retain them for the purpose of satisfying awards under the Company's employee share plans.

Since 8 May 2026, the Company has purchased 6,464,816 shares at a cost of $97,543,114.44.

Following the purchases of these shares, the Company holds 30,087,389 of its ordinary shares in treasury. The Company's issued share capital, with one voting right per share consists of 847,646,361 ordinary shares of US20¢ each (excluding treasury shares). The figure of 847,646,361 should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of UKLR 9.6.6R.

The table below contains detailed information about the purchases made as part of the buyback programme.

Schedule of Purchases

Shares purchased: 1,204,120 (ISIN: GB0009223206)

Dates of purchases: 5 June 2026 to 11 June 2026

Investment firm: Merrill Lynch International

Aggregate information:

Venue	Volume weighted average price paid per ordinary share (GBP)	Number of ordinary shares repurchased	Lowest price per ordinary share (GBP)	Highest price per ordinary share (GBP)
London Stock Exchange	11.5122	1,204,120	11.2750	11.8050
CBOE Europe BXE	-	-	-	-
CBOE Europe CXE	-	-	-	-
Turquoise	-	-	-	-
Aquis Stock Exchange	-	-	-	-

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a schedule of individual trades by Merrill Lynch International is available below:

Individual Transactions:

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/1272I_1-2026-6-12.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END